ENvue Medical (FEED) Cash from Investing Activities (2014 - 2026)
ENvue Medical's (FEED) quarterly Cash from Investing Activities came in at -$27000.0 in Q2 2026, down 575.0% year-over-year from $5684.2 in Q2 2025, and down 58.82% quarter-over-quarter from -$17000.0 in Q1 2026.
Powered by 
Analysis
ENvue Medical (FEED) Cash from Investing Activities (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Cash from Investing Activities for 11 consecutive years, with -$27000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 575.0% year-over-year to -$27000.0 in Q2 2026; TTM through Jun 2026 was -$95000.0, a 168.35% decrease from a year earlier, with the FY2025 full-year figure at $88000.0, up 3033.33% from the prior year.
- Cash from Investing Activities was -$27000.0 for Q2 2026 at ENvue Medical, down from -$17000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $143000.0 in Q1 2025 and troughed at -$28000.0 in Q3 2025.
- A 5-year average of $3545.5 and a median of -$2000.0 in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities jumped 14400.0% in 2025 and sank 575.0% in 2026, its largest moves.
- Over 5 years, Cash from Investing Activities stood at $1000.0 in 2022, then slumped by 200.0% to -$1000.0 in 2023, then sank by 100.0% to -$2000.0 in 2024, then plunged by 1050.0% to -$23000.0 in 2025, then fell by 17.39% to -$27000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$27000.0 (Q2 2026), -$17000.0 (Q1 2026), and -$23000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -108.50 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | -27,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -3,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Jun 30, 2017 | -2,000.00 |
| Jun 30, 2016 | -1,000.00 |
| Mar 31, 2016 | -7,000.00 |
| Jun 30, 2015 | -1,000.00 |